MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Nature

Volumn 431, Issue 7012, 2004, Pages 1112-1117

  Shachaf, Catherine M ^a   Kopelman, Andrew M ^a   Arvanitis, Constadlna ^a   Karlsson, Åsa ^a   Beer, Shelly ^a   Mandl, Stefanie ^b   Bachmann, Michael H ^b   Borowsky, Alexander D ^c   Ruebner, Boris ^c   Cardiff, Robert D ^c   Yang, Qiwei ^a   Bishop, J Michael ^d   Contag, Christopher H ^b   Felsher, Dean W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOLOGICAL ORGANS; BIOMARKERS; GENES; MOLECULAR STRUCTURE; PATIENT TREATMENT;

BILIARY CELLS; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR CARCINOMA; INACTIVATION;

TUMORS;

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 8; TUMOR MARKER; MYC PROTEIN;

MEDICINE;

ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER INVASION; CANCER REGRESSION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CLONE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE INACTIVATION; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ONCOGENE MYC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE STRUCTURE; TUMOR CELL; ANIMAL; APOPTOSIS; BILE DUCT; CELL TRANSFORMATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUMINESCENCE; METABOLISM; MOUSE MUTANT; PATHOLOGY; STEM CELL; TRANSGENIC MOUSE;

ANIMALIA;

ANIMALS; APOPTOSIS; BILE DUCTS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; LUMINESCENT MEASUREMENTS; MICE; MICE, SCID; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 7744220635     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03043     Document Type: Article

References (30)

1. Nowak, A. K., Chow, P. K. & Findlay, M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur. J. Cancer 40, 1474-1484 (2004).
2. Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235-248 (1991).
3. Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nature Rev. Cancer 3, 375-380 (2003).
4. Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102-104 (2002).
5. Coleman, W. B. Mechanisms of human hepatocarcinogenesis. Curr. Mol. Med. 3, 573-588 (2003).
6. Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D. & Brinster, R. L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4, 715-724 (1989).
7. Murakami, H. et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53, 1719-1723 (1993).
8. Wu, Y, et al. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. Oncogene 21, 1518-1526 (2002).
9. Simile, M. M. et al. Downregulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25, 333-334 (2003).
10. Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad. Sci. USA 93, 10933-10938 (1996).
11. Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999).
12. Venook, A. P. Hepatocellular carcinoma. Curr. Treat. Options Oncol. 1, 407-415 (2000).
13. Thorgeirsson, S. S. Hepatic stem cells in liver regeneration. FASEB J. 10, 1249-1256 (1996).
14. Fausto, N. Hepatocyte differentiation and liver progenitor cells. Curr. Opin. Cell Biol. 2, 1036-1042 (1990).
15. Fausto, N. & Campbell, J. S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117-130 (2003).
16. Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353-1360 (2001).
17. Uhr, J. W., Tucker, T., May, R. D., Siu, H. & Vitetta, E. S. Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Res. 51, 5045s-5053s (1991).
18. Demicheli, R. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol 11, 297-306 (2001).
19. Naumov, G. N., MacDonald, I. C., Chambers, A. F. & Groom, A. C. Solitary cancer cells as a possible source of tumour dormancy? Semin. Cancer Biol. 11, 271-276 (2001).
20. Uhr, J. W., Scheuermann, R. H., Street, N. E. & Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nature Med. 3, 505-509 (1997).
21. Riethmuller, G. & Klein, C. A. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol 11, 307-311 (2001).
22. Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153 (1995).
23. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
24. Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452 (2003).
25. Al-Hajj, M. B., Wicha, M. W., Weissman, M. & Clarke, I. M. F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43-47 (2004).
26. Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197-205 (1995).
27. Lotem, J. & Sachs, L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339-346 (2002).
28. Leffert, K. S. & Skelly, K. in Cell Culture Methods for Molecular and Cell Biology (eds Barnes, D. W., Sirbasku, D. A. & Sato, G. H.) 43-55 (Alan R. Liss, New York, 1984).
29. Edinger, M. et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101, 640-648 (2003).
30. Poilack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet, 23, 41-46 (1999).